Original language | English |
---|---|
Article number | 1580 |
Journal | Viruses |
Volume | 13 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Viruses, Vol. 13, No. 8, 1580, 08.2021.
Research output: Contribution to journal › Editorial
TY - JOUR
T1 - SHARED
T2 - An international collaboration to unravel hepatitis C resistance
AU - Howe, Anita Y.M.
AU - Ceccherini-Silberstein, Francesca
AU - Dietz, Julia
AU - Popping, Stephanie
AU - Grebely, Jason
AU - Rodrigo, Chaturaka
AU - Lennerstrand, Johan
AU - Douglas, Mark W.
AU - Parczewsk, Milosz
AU - Harrigan, P. Richard
AU - Pawlotsky, Jean Michel
AU - Garcia, Federico
AU - SHARED Collaborators
AU - Seguin-Devaux, Carole
N1 - Funding Information: Conflicts of Interest: J.M.P. has been an advisor and/or speaker for Abbvie, Assembly Biosciences, Arbutus, Merck, Gilead, Regulus and Memo Therapeutics. J.D. receives research support from Gilead. A.Y.M.H. is a consultant for Boston Pharmaceuticals. J.G. reports grants and personal fees from Abbvie, Gilead Sciences, Merck, and Cepheid and grants from Hologic and Indivior, outside the submitted work. Funding Information: No financial support was received for the writing of this article. The initial SHARED development was funded in part by Merck and a User Partnership Program grant from Genome British Columbia to P.R.H and A.Y.M.H (UPP029). The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. J.G. is supported by an NHMRC Investigator Grant (1176131). Acknowledgments: We want to express our deep gratitude to our patients who participated in this project. In addition, we are grateful to all contributing collaborators, staff, and research scientists who have spent numerous hours organizing the data. Special thanks to Naveed Janjua and Mel Krajden for their vote of confidence and providing SHARED the infrastructure and administrative support at the British Columbia Centre for Disease Control, Canada. This manuscript was written in memory of Charles Boucher. His dynamism, leadership, and unyielding enthusiasm in promoting virology education have inspired the SHARED community. Funding Information: Funding: No financial support was received for the writing of this article. The initial SHARED development was funded in part by Merck and a User Partnership Program grant from Genome British Columbia to P.R.H and A.Y.M.H (UPP029). The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. J.G. is supported by an NHMRC Investigator Grant (1176131).
PY - 2021/8
Y1 - 2021/8
UR - http://www.scopus.com/inward/record.url?scp=85112724133&partnerID=8YFLogxK
U2 - 10.3390/v13081580
DO - 10.3390/v13081580
M3 - Editorial
C2 - 34452444
AN - SCOPUS:85112724133
SN - 1999-4915
VL - 13
JO - Viruses
JF - Viruses
IS - 8
M1 - 1580
ER -